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Abstract 
 The population of people surviving cancer is continually increasing and currently cancer 
survivors represent approximately 3.7% of the American population and 3% of the UK 
population. There is limited and inconclusive empirical evidence regarding the long-term health 
and wellbeing of cancer survivors. 
Methods: 289 cancer survivors and 262  matched-age and sex patients from the same group of 
General (primary care) Practices completed postal questionnaires measuring health and 
wellbeing, health service utilisation and satisfaction and health care needs. 
Main results: Cancer survivors reported poorer health and wellbeing and health service 
utilisation than the general population. Despite this poorer health the majority of cancer survivors  
reported satisfaction with services and  almost two-thirds of survivors did not report any needs. 
Conclusions: The majority of cancer survivors do not appear to require additional support 
services. There is, however, a subgroup of survivors who warrant specialist support, particularly 
survivors who are older, experience late effects and have had adjuvant treatments. Future 
research should focus on developing methods that could be used in routine clinical practice to 
identify’ at risk’ or vulnerable patients and to provide appropriate and timely support. 
 
 
 
 
 
 
 
 
 
 
Introduction 
The population of people surviving cancer is continually increasing and currently cancer 
survivors represent approximately 3.7% of the American Population and 3% of the UK 
population [1-2]. Prevalence figures in the UK are expected to reach 4 million by 2020 [2]. There 
is limited empirical evidence regarding the long term health and wellbeing of cancer survivors, 
and even less information regarding health care needs and health service utilisation. The few 
international studies available [3-10] suggest that cancer survivors experience poorer health and 
wellbeing and have a higher level of health service utilization compared to the general 
population. These studies however are limited methodologically and there are no studies that 
have been undertaken in Northern Ireland or in the Republic of Ireland. Furthermore, there is 
inconsistent evidence available regarding the prevalence of unmet need [11-18].  
Data is also lacking regarding late effects of cancer treatment.  It is well recognized that cancer 
and its treatment is associated with the development of physical and psychological problems that 
may not dissipate over time [19]. These problems may emerge at various time points along the 
illness trajectory. Whilst some of these problems are related to cancer treatment and appear 
during or immediately after treatment others do not manifest until months or even years later. 
The combined effect of the lack of research in this area including a paucity of studies about 
illness trajectories makes it difficult to differentiate between problems that are long-term or late 
effects of varying duration. The development of specialist services for cancer survivors is 
receiving specific attention within UK health policy [20]. It is important that the match between 
health and wellbeing, need for services and patterns of health service use are understood to 
ensure that resources are targeted appropriately.  
Empirical data regarding the health and wellbeing of cancer survivors is sparse and the few 
studies available are inconclusive. This study was undertaken in order to map patterns of health 
status and wellbeing, health service utilization and health care needs of cancer survivors in order 
to inform service development and improvement. 
 
 
Methods 
The Northern Ireland Primary Care Research Network (NI PCRN) comprises research-minded 
General Practices and each Practice was paid an honorarium for .the time that they spent 
facilitating the conduct of the survey. Practices or surgeries spanned the five Health and Social 
Care Trusts (or care provider agencies) in Northern Ireland including urban and rural areas.  
Cancer survivors (2-15 years post diagnosis) in each participating GP practice were identified via 
the Northern Ireland Cancer Registry (NICR). The NICR registers all cancers diagnosed in 
Northern Ireland, including non-melanoma skin cancer. A study number was assigned to every 
live registered cancer patient in the participating GP practices. A random number generation 
package (www.random.org) was used to generate a random sample of 865 cancer survivors. 
GPs screened their list of randomly selected patients and were asked to confirm whether or not a 
patient: 
• had a cancer diagnosis during adulthood 
• was not over 80 years old 
• was alive  
• was not receiving palliative or end of life care  
• was not currently receiving active treatment for cancer i.e. chemotherapy, radiotherapy or 
surgery (this did not include medications for prophylactic purposes or hormone 
treatment) 
• had no cognitive impairment that would limit their ability to self-complete the 
questionnaires 
• GPs were not aware of any other reason why a patient should not be asked to participate 
in the study   
Participants eligible for inclusion were forwarded a pre-prepared addressed questionnaire pack.  
A sample of control patients who did not have a diagnosis of cancer (but who may have had 
other illnesses) was obtained by searching each GP’s database for age and gender-matched 
patients (approximating 1 per eligible survivor, calculated on the basis of an attrition rate of 40-
50%).  Surgeries were requested to note the age of the youngest and oldest male/female on the 
list of eligible patients. Every 20th person on the list was selected. 
GPs were asked to confirm whether or not each control patient: 
• had never had a diagnosis of cancer 
• was alive 
• was not receiving end of life care 
• had no cognitive impairment that would limit their ability to self-complete the 
questionnaires 
• there was no reason why a patient should not be asked to participate in the study 
 
Potential participants who had not replied within 2 weeks of receiving a questionnaire pack 
received a reminder pack. Reminder calls to non-respondents were conducted 6 weeks following 
the first mail out. 
Measures 
The survey questionnaire for survivors comprised questions on the following topic areas: 
• Socio-demographic questions: e.g. age, sex, employment 
• Health and wellbeing: health status was assessed using the (SF-36) [21]. The SF-36 is 
the most common health status measure [21] and it has been used extensively in both 
cancer and non-cancer populations. While a cancer specific measure could have provided 
more detailed information on cancer related symptoms it would not have been 
appropriate for use in the general population. The results or scores on a completed SF-36 
may be calculated to form a mental health summary component score and a physical 
health summary component score. 
• Health service utilisation: Health service use based on two questions from the English 
Macmillan Health and Well-being Survey [22] and one question assessing satisfaction 
with services. 
• Health and social care needs: Need for care was assessed using an abbreviated and 
adapted version of Cancer Survivor Unmet Need (CaSUN) questionnaire [11]. A scoping 
review of studies that used the CaSUN showed that cancer survivors regardless of cancer 
site had 7 common needs. Survivors indicated on the short version of the CaSUN if they 
experienced each need, whether the need was met or unmet and the severity of each need.  
• Late effects: The severity of any late effects related to cancer and/or treatment was 
recorded on an established self-reported late effect scale [23].  
The questionnaire pack for control patients was equivalent to  the pack that survivors received 
except for the omission of questions on need for care and late effects. 
In keeping with practice reported in previous studies that used the SF-36 to assess health status,   
data was imputed into an unanswered question when at least 50% of the questions in a given 
domain were answered [24]. A mean score for each domain was calculated based on the total 
number of responses provided by participants. Each mean score was multiplied by the total 
number of items within the relevant domain to impute scores of how survivors may have 
responded had the questionnaire been fully completed. Individuals that did not answer 50% or 
more items in any given domain were not included in analysis. Regarding all other questions 
(health service utilisation, needs and illnesses) a missing response was considered to be a ‘no’ 
response. 
Two multiple linear regression models were generated using the physical component summary 
scores (PCS) and the mental summary component scores (MCS) as dependent variables. The 
following independent variables were entered into each model: age in years as a continuous 
variable; sex with males used as the reference category; cancer site with melanoma entered as the 
reference category; years since diagnosis with 20+ year entered as the reference category; 
reported unmet needs included no reported unmet needs as the reference category and at least 
one reported unmet need; health service utilisation frequency was entered as a continuous 
variable; treatment type received was categorised as radiotherapy only, chemotherapy only, 
surgery only as the reference category and combined therapies; number of co-morbidities was 
entered as a continuous variable and late effects was categorised into mild, moderate and severe 
with no late effects as the reference category. 
 
 
Results 
Two hundred and eighty-nine survivor questionnaires were completed and returned; the response 
rate for survivors was 47% (289/613). A total of 262 control questionnaires were completed and 
returned; the response rate was 43% (262/614). The average age of cancer survivors who 
responded was 63 years old and 59% (171) were female. Approximately 34% had been 
diagnosed with breast cancer, 18% with prostate cancer and 14% with colorectal cancer. Time 
since diagnosis ranged from one to twenty or more years. Over half of respondents had been 
diagnosed within the past six years. There were no statistically significant differences between 
survivors that responded and those that did not in terms of age, sex, and time since diagnosis 
(Table 1). Furthermore, there were no significant differences between cancer survivors and 
controls in terms of age or sex. 
 Table 1: Chi-squared tests comparing respondents and non-respondents in terms of sex, cancer site 
and time since diagnosis 
Respondents         
                             n (%) 
Non-respondents 
 n (%) 
X2 df p value 
Sex 
Male  
Female 
 
118 (41) 
171 (59) 
 
135(41) 
192 (59) 
 
.01 
 
1 
 
.91 
Cancer Site 
Breast 
Prostate 
Colorectal 
Gynecological 
Melanoma  
Hematological 
Urinary  
Head and neck 
Upper gastro-
intestinal  
Other 
 
 
99 (34) 
51 (18) 
40 (14) 
26 (9) 
21 (7) 
19 (6) 
18 (6) 
8 (3) 
 
5 (2) 
2 (1) 
 
 
86 (26) 
35 (11) 
47 (14) 
42 (13) 
25 (8) 
31 (9) 
29 (9) 
16 (5) 
 
4 (1) 
12 (4) 
 
 
21.68 
 
9 
 
.01 
Years since 
diagnosis 
1-3 years  
4-6 years  
7-9 years  
9-11 years  
12-15 years  
16-20 years  
20+ years  
 
 
90 (31) 
63 (23) 
48 (17) 
34 (12) 
27 (9) 
21 (7) 
6 (1) 
 
 
84 (26) 
72 (22) 
53 (16) 
32 (10) 
39 (12) 
41 (12) 
8 (2) 
 
 
10.12 
 
 
6 
 
 
.12 
                    Figure 1: Flowchart showing sampling and recruitment process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Random sample of 865 cancer 
survivors generated from NICR 
20 x General Practices = random 
sample 35/50 survivors 
9 practices=35 patients, 11 
practices= 50 patients 
 
 
249 survivors excluded: 
64 deceased 
61 left GP practice 
26 memory 
problems/Alzheimer’s 
22 palliative 
76 GP advice  
865 cancer survivors screened   
616 survivors deemed eligible 
for the study. 
 
 Random sample of 616 age and 
gender-matched controls 
generated from General Practice. 
 
616 assessment packs mailed to 
survivors and 616 mailed to 
controls. 
 
2 controls excluded at this stage 
due to diagnosis of cancer. 
262 control assessment packs 
returned. 
84 did not give consent 
268 non-responses. 
 
3 survivors excluded at this stage due 
to death (n=1), recurrence (n=1) and 
wrong address (n=1) 
289 survivor assessment packs 
returned. 
94 did not give consent 
230 non-responses. 
 
262 / 614; 43% response rate 289 / 613; 47% response rate 
Independent samples t-tests were conducted to examine whether or not there were statistically 
significant differences between survivors versus controls. Survivors reported significantly poorer 
health than the General Practice population in terms of physical functioning, physical role 
limitations, emotional role limitations, mental health, vitality, general health perception and 
social functioning. There was no statistically significant difference in scores for survivors and 
controls in terms of change in health in the past year or pain scores (See Table 1). Cancer 
survivors reported a significantly lower PCS and a lower MCS and a significantly greater 
number of co-morbidities compared to controls (see Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Independent t-test comparisons between survivors and controls on the SF-36 
domains, SF-36 component scores and number of co-morbidities. 
Domain 
 
Group n Mean SD T Df p 
value* 
Mean 
Difference 
CI 
lower 
CI 
upper 
Physical 
Function 
 
survivor 
control 
 
286 
262 
 
62.83 
74.60 
 
33.51 
29.05 
-4.40 
 
544 
 
0.012 
 
 
-11.77 
 
-17.02 
 
 
-6.52 
 
Role 
Limitations: 
Physical 
survivor 
control 
 
276 
256 
57.76 
72.95 
44.95 
40.80 
 
-4.09 
 
530 
 
0.012 
 
 
-15.19 
 
 
-22.49 
 
 
-7.89 
 
Role 
Limitations: 
Emotional 
survivor 
control 
 
280 
252 
66.61 
81.22 
43.73 
35.70 
-4.24 
 
 
525 
 
 
0.012 
 
 
-14.61 
 
 
-21.38 
 
 
-7.84 
 
 
Mental 
Health 
 
survivor 
control 
 
284 
261 
 
73.18 
78.23 
 
19.52 
18.04 
 
-3.13 
 
 
543 
 
 
0.024 
 
-5.05 
 
-8.22 
 
 
-1.88 
 
Vitality 
 
 
survivor 
control 
 
284 
261 
54.83 
62.03 
 
24.75 
22.35 
 
-3.57 
 
 
543 
 
0.012 
 
 
-7.20 
 
 
-11.16 
 
 
-3.24 
 
 
General 
Health 
Perception 
survivor 
control 
 
284 
260 
 
59.32 
68.31 
 
24.75 
22.35 
 
-4.45 
 
 
542 
 
 
0.012 
 
 
-8.98 
 
 
-12.95 
 
 
-5.02 
 
 
Change in 
Health 
survivor 
control 
 
287 
261 
 
53.14 
49.43 
 
22.39 
16.54 
 
2.22 
 
524 
 
0.324 
 
 
3.71 
 
 
-0.43 
 
6.70 
 
 
Pain 
 
 
survivor 
control 
 
287 
260 
68.69 
74.39 
 
30.16 
28.75 
 
-2.27 
 
 
544 
 
 
0.288 
 
 
-5.71 
 
 
-10.66 
 
 
-0.76 
 
 
Social 
Functioning 
 
survivor 
control 
 
288 
261 
 
78.75 
86.15 
 
26.18 
23.08 
 
-3.52 
 
 
547 
 
 
0.012 
 
 
-7.40 
 
 
-11.53 
 
 
-3.27 
 
Physical 
Component 
Score 
 
survivor 
control 
 
272 
251 
42.74 
49.94 
 
18.86 
16.89 
 
-4.61 
 
 
521 
 
 
0.012 
 
 
-7.20 
 
 
-10.27 
 
 
-4.13 
 
Mental 
Component 
Score 
survivor 
control 
 
272 
251 
 
47.53 
50.51 
 
11.56 
9.71 
 
-3.18 
 
   
516.56 
 
 
0.012 
 
 
-2.98 
 
 
 
-4.81 
 
 
-1.15 
 
 
 
Number of 
Co-
morbidities 
survivor 
control 
 
289 
262 
 
1.74 
1.31 
 
1.73 
1.29 
 
3.34 
 
 
529 
 
 
0.012 
 
 
0.43 
 
0.18 
 
0.69 
 
 
*Independent t-test, Bonferroni adjusted. 
 
 
 
Over half of cancer survivors (55%) reported that they did not experience late effects. Less than 
one fifth (18%) experienced mild late effects and respondents indicated that these mild late 
effects were managed with medication or minor lifestyle changes. Approximately 12% 
experienced moderate effects that required providing treatment and some assistance. The 
remaining 8% of cancer survivors experienced severe late effects which extremely restricted 
their daily activities (7% did not answer question). 
Health and social care needs and satisfaction with services 
Approximately 60% of survivors reported ‘no need’. The top unmet need was the need for better 
coordinated care (25%) though only 12% of survivors described this need as strong. Need for 
support with health insurance and travel insurance was identified by 23 % of cancer survivors, 
the majority of whom described this need as moderate. The third ranked unmet need was the 
need for help to manage anxiety and recurrence concerns related to cancer (21%), though a 
serious or severe degree of this need was experienced by only 1%. Hospital car parking was 
identified as a need by 15% of survivors. The fifth unmet need was the need for a key health 
worker (14%). Most survivors (94%) did not need additional information support for themselves 
or for their partners (see Tables 3 and 4) 
Table 3: Proportion of survivors reporting severity of needs and unmet need 
  Need Strength   
 
Need 
 
No need 
 
Weak 
 
Moderate 
 
Strong 
 
Total unmet 
Recurrence concerns 
 
79% 
(194) 
9% 
(22) 
8.2% 
(20) 
1.4% 
(9) 
21% 
(51) 
Co-ordinate care 
 
74.5% 
(181) 
4.5% 
(11) 
8.6% 
(21) 
12.3% 
(30) 
25.4% 
(62) 
Health and travel 
insurance 
76.6% 
(200) 
5.4% 
(14) 
11.5% 
(30) 
6.5% 
(17) 
23.4% 
(61) 
Hospital car-parking 
 
85.1% 
(222) 
4.6% 
(12) 
5% 
(13) 
5.4% 
(14) 
15% 
(39) 
Key health worker 
 
85.7% 
(174) 
5.9% 
(12) 
6.9% 
(14) 
1.5% 
(3) 
14.3% 
(29) 
Up to date 
information 
94% 
(224) 
2% 
(5) 
4% 
(10) 
4% 
(10) 
10% 
(25) 
Partner information 
 
93.9% 
(247) 
0.8% 
(2) 
2.7% 
(7) 
2.7% 
(7) 
7.1% 
(16) 
*Numbers do not always add up to 289 as some survivors did not answer questions 
Table 4: Satisfaction with health services 
Group 
 
Very 
satisfied 
Satisfied Dissatisfied Very 
dissatisfied 
 n (%)  n (%) n (%) n (%) 
Survivor 
 
143(50) 112 (40) 3 (1) 3 (1) 
Control 
 
118 
(45) 
104 (40) 5 (2) 3 (1) 
 
Health service use 
Cancer survivors paid significantly more visits to a GP, primary care professionals other than 
their GP, outpatients and complementary therapists than the control group in the previous 12 
months. There were no significant differences in the use of mental health services, allied health 
professionals, district nurses and hospital stay between cancer survivors and the General Practice 
population.  
Predictors of health and wellbeing 
Late effects and treatment type were significant predictors of survivors MCS. Cancer survivors 
who were older, more frequent users of health services and experienced more illnesses and 
severe late effects reported significantly poorer PCS.  
 
 
 
 
 
 
 
 
Table 5: Multiple linear regression analysis of cancer survivor characteristics and physical 
and mental component summary scores 
Explanatory 
variable 
n Mental 
Comp 
Mean 
score 
** Fully adjusted 
mean (95% CI) p 
value 
Physical 
Comp 
Mean 
score 
** Fully adjusted mean (95% 
CI) p value 
Age 272 42.7 -0.29 (-0.48, -0.09) 
p=0.004 
47.53 p= 0.28, 0.08(-0.07,0.24) 
Sex 
 
Male (110) 
Female (162) 
43.11 
42.49 
p=0.86 
-0.64 (-7.83, 6.55) 
47.59 
47.49 
 p=0.68,-1.14(-6.80,4.42) 
Cancer site 
 
Melanoma (20) 
Urinary (18) 
Other (6) 
Breast (93) 
Colorectal (35) 
Gynae (25) 
Head and Neck 
(8) 
Hematological 
(18) 
Prostate (49) 
47.64 
42.16 
27.13 
44.21 
36.39 
45.22 
39.81 
 
38.60 
 
45.33 
p=0.36 
-0.12(-12.96,12.72) 
-5.46(-22.47,11.56) 
-5.36(-4.04,14.76) 
2.86(-8.53,14.26) 
5.84(-4.82,16.48) 
13.35(-5.53,32.23) 
 
5.74(-7.07,18.54) 
 
8.42(-3.52,20.36) 
49.24 
46.78 
42.94 
48.34 
44.73 
48.68 
42.56 
 
47.26 
 
48.48 
p=0.79,  
-3.40 (-13.42, 6.62) 
-5.00 (-18.27, 8.28) 
0.15 (-7.18, 7.48) 
-4.04 (-12.94, 4.85) 
-0.02 (-8.33, 8.30) 
2.97 (-11.77, 17.70) 
 
1.04 (8.95, 11.02) 
 
-0.08 (-9.40, 9.23) 
Years since 
diagnosis 
 
20+ (6) 
1-3 (86) 
4-6 (60) 
7-9 (42) 
9-11(34) 
12-15 (25) 
16-20 (19) 
31.84 
40.97 
41.61 
44.13 
42.12 
48.35 
41.46 
p=0.10. 
3.32(-12.46,19.09) 
2.31(-13.62,18.24) 
1.99(-18.14,14.17) 
-0.99(-17.39,15.60) 
10.55(-6.72,27.83) 
6.50(-10.69,23.69) 
 
44.29 
45.24 
47.07 
48.15 
48.98 
52.92 
49.36 
p=0.25 
-3.67 (-15.99, 8.64) 
-3.82 (-16.25, 8.62) 
-4.85 (-17.45, 7.76) 
-4.17 (17.04, 8.70) 
4.34 (-9.14, 17.82) 
-1.14 (-14.55, 12.27) 
Need 
met/unmet 
No need (163) 
Need (109) 
47.31 
35.90 
p=0.47 
-1.60(-5.93, 2.72) 
50.20 
43.55 
p=0.06  
-3.21(-6.58, 0.17) 
HSU 271 42.65 p=0.04 
-0.14 ( -0.27, -0.01) 
47.50 P=0.44 
-0.04 (-0.15, 0.06) 
Treatment 
Type 
Surgery (50) 
Radiotherapy 
(14) 
Chemotherapy 
(9) 
Hormone (9) 
Combination 
(121) 
55.48 
36.35 
 
45.25 
 
41.29 
41.61 
p=0.08 
-10.75(-19.21, -2.29) 
 
-5.01 (-15.70,5.69) 
 
-7.78 (-16.75, 2.18) 
-5.73 (-10.77,-0.69) 
51.75 
47.01 
 
44.79 
 
50.62 
45.49 
 
p=0.03 
-5.55 (-12.16, 1.05) 
-7.25 (-15.59, 1.10) 
 
-2.89 (-10.66, 4.89) 
-6.24 (-10.17, -2.31) 
Illnesses 272 42.74 p<0.001 
-3.40 (-4.62, -2.18) 
47.53 p=0.03 
-1.07 (-2.02, -0.12) 
Late effects No late effects 
(155) 
Mild (47) 
Moderate (32) 
 
Severe (21) 
49.62 
 
45.74 
24.00 
 
17.17 
p<0.001 
 
-7.30 (-12.33, -2.28) 
-22.82 
(-28.87, -16.77) 
-27.52  
(-35.22, -19.81) 
49.93 
49.15 
39.39 
38.43 
p<0.001 
-1.10 (-5.02, 2.82) 
-8.49 (-13.21, -3.78) 
-10.52(-16.53,14.51) 
 
Table 6: Multiple linear regression analysis of cancer caregiver characteristics and physical 
and mental component summary scores 
Variable 
 
 
n Mean  
Mental 
comp 
score 
** Fully adjusted mean 
(95% CI) p value 
Mean 
physical 
comp score 
** Fully adjusted mean 
(95% CI) p value 
Age 80 44.1 -0.25 (-0.7, 0.2) p=0.25 45.8 0.3 (-0.1, 0.7) p=0.17 
Sex Male (32) 
Female (57) 
47.2 
42.9 
p=0.90 
0.62 (-9.8, 11.0) 
49.0 
44.0 
p=0.91 
-0.6 (-9.9, 11.1) 
 
Cancer site 
 
Melanoma(3) 
Breast (29) 
Colorectal (10) 
Gynecological (4) 
Head and Neck 
(6) 
Hematological (8) 
Prostate (21) 
40.2 
48.7 
35.5 
39.2 
 
41.4 
 
43.8 
 
45.5 
p=0.19 
25.3 (-4.9, 55.4) 
22.3 (-8.4, 53.0) 
0.66 (-37.0, 38.3) 
27.3 (-10.0, 64.6) 
26.4 (-3.8, 56.7) 
 
20.2 (-10.8, 15.3) 
 
38.6 
47.7 
45.4 
46.9 
 
45.7 
 
44.9 
 
45.4 
p=0.92 
14.7 (-15.8, 45.1) 
15.9 (-15.1, 47.0) 
16.5 (-21.5, 54.5) 
 
10.8 (-26.9, 48.5) 
 
 
16.8 (-13.7, 47.3) 
 
11.7 (-19.7, 43.0) 
 
 
Years since 
diagnosis 
 
20+ (3) 
1-3(33) 
4-6(22) 
7-9(12) 
9-11(14) 
12-15 (4) 
16-20 (1) 
36.7 
45.2 
43.5 
43.9 
43.1 
51.8 
62.6 
p=0.84 
3.1 (-19.3, 25.5) 
-2.8 (-24.8, 19.2) 
-5.0 (-27.7, 17.8) 
-2.5 (-29.5, 24.6) 
-0.4 (-28.2, 27.4) 
 
 
43.7 
45.5 
47.4 
43.1 
43.8 
53.5 
57.7 
p=0.98 
0.99 (-21.6, 23.6) 
2.9 (-19.4, 25.1) 
-1.7 (-24.6, 21.3) 
1.6 (-25.7, 28.9) 
5.0 (-23.1, 33.1) 
 
 
HSU 86 44.1 -0.23(-0.5,0.7) p=0.13 45.6 -0.3 (-0.60, -0.01) 
p=0.04 
Illnesses 89 44.5 -5.3 (-8.9, -1.7) 
P=0.05 
45.8 -0.3 (-3.9, 3.4) p=0.88 
 
Hours per 
week spent 
caring  
 
22+ (14) 
1-7 (8) 
8-14 (4) 
15-21 (22) 
53.2 
40.6 
43.1 
33.7 
p=0.09 
-2.5 (-19.4, 14.5) 
-7.3 (-23.4, 8.9) 
-14.2 (-25.5, -2.9) 
46.4 
43.9 
44.5 
40.5 
p=0.22 
11.6 (0.2, 23.0) 
9.7 (-7.1, 26.5) 
7.1 (-9.0, 23.1) 
 
  
 
Discussion 
 Compared to age- and gender- matched controls, cancer survivors reported significantly poorer 
scores in relation to physical and mental wellbeing. A comparison of the SF-36 UK population 
norms for people aged 60-64 [24] indicates that cancer survivors in NI have poorer health 
domain and component scores. These findings differ from recent UK studies that suggest that 
health status [18] and or psychological difficulties [25-26] of cancer survivors are consistent with 
or better than population norms.  This difference may be due to the fact that previous UK studies 
focused on long-term survivorship (5+ years post-diagnosis) or did not include early-stage 
survivors. However, this study did not find any association between time since diagnosis and 
health and wellbeing.   Overall, previous international studies demonstrate that cancer survivors 
fair worse than the general population in terms of health and wellbeing [3-10]. It is important to 
bear in mind the methodological difficulties of conducting like-with-like comparisons between 
the health and wellbeing estimates presented here and in earlier studies as the majority of studies 
did not use validated measures or did not exclude patients who remained in active treatment. In 
addition, it is difficult to discern the clinical meaning of SF-36 scores and of statistically 
significant differences between survivors and the General Practice control group due to a lack of 
studies in this area.   
Approximately 40% of cancer survivors reported late effects; 18% reported mild late effects and 
20% reported moderate or severe late effects. There is little epidemiological data regarding the 
prevalence of late effects in adult cancer survivors. The limited evidence suggests that late 
effects may occur in 11-30% of cases [12, 27]. The extent to which accurate comparisons can be 
made between prevalence estimates across studies is restricted due to conceptual and 
methodological differences. However, a higher proportion of cancer survivors in Northern 
Ireland appear to report late effects and to report more severe late effects. The prevalence of late 
effects is likely to rise given the growing population of survivors.  
 
Alongside living with late effects, cancer survivors reported a significantly greater number of co-
morbidities compared to the General Practice population. On average, cancer survivors reported 
experiencing 1.74 co-morbidities compared to 1.31. This result is consistent with other studies, 
which found that between 69-88% of cancer survivors reported one or more co-morbid 
conditions [28-29]. However, similar to earlier studies, it is difficult to be clear about the nature 
and direction of this relationship. For example, it is difficult to disentangle the extent to which 
co-morbidity may be due to poor lifestyle choices such as smoking and due to cancer and its 
treatment. Nonetheless, it is important to note particularly by health planners and providers that 
cancer survivors tend to live with a significantly higher number of co-morbidities and late 
effects; and to consider this patient profile during follow-up care and treatment.  
Cancer survivors reported significantly higher health service utilization. The most frequently 
reported health services used by cancer survivors were visits to their General Practice and 
hospital-based outpatient appointments. There were no significant differences in use of specialist 
services such as mental health.  Some studies have found that cancer survivors had greater use of 
GP services [30, 22] and medical specialists; other studies have presented mixed evidence [31]. 
Differences between health care systems and methods of recording utilization may explain 
between-study variation. 
Despite the poor health outcomes, approximately 90% of cancer survivors reported that they 
were satisfied with the services that they received. Furthermore, the majority of cancer survivors 
did not report any needs for services and those that did, reported low level need for support with 
regards to co-ordinated care, health and travel insurance, recurrence concerns and hospital car 
parking. These findings, that the majority of survivors do not have unmet needs, are consistent 
with other UK studies [12, 17-18]. There is, however, variation between unmet need levels 
across countries [11, 13-16]. This may be due partly to different health systems and possibly to 
cultural factors. For example, UK and Irish cancer survivors may be less likely to vocalise a need 
for support compared to survivors elsewhere. The study has a number of limitations. A strength 
and weakness of the study is that it is based upon participants’ views of their health and 
wellbeing, service use, satisfaction and health care needs. Self-report measures may be subject to 
recall bias and survivors may over- or under-estimate their health and health related behaviors. 
The inclusion of more objective measures to record for example physical functioning or the use 
of secondary service data to collect information about health service use and drug use would be 
beneficial. The research team is exploring the possibility of using data-linkage across service 
data sets to investigate the health and health care of cancer survivors. The ethical requirements 
and postal nature of this survey did not allow the research team to make direct contact with 
participants. A further limitation is the inherent difficulties in defining and measuring late effects 
and the lack of reliable and valid measures. In light of these difficulties, we choose a measure 
that was low in participant burden and had been tested with this patient group.  
Overall, the data collected from this large representative sample of cancer survivors contributes 
to the limited empirical data about cancer survivors, particularly in Ireland.  Currently, health 
care providers and policy makers within the UK and Ireland are giving consideration to ways in 
which to provide care for cancer survivors. The results of this study indicate that whilst survivors 
may have poorer health than a General Practice population, they are generally satisfied with the 
services that they receive and they do not require additional support services. There is, however, 
a subgroup of survivors who may warrant specialist support, particularly survivors who 
experience late effects. Future research should focus on methods of identifying cancer survivors 
according to their risk status and vulnerability to suffer illness and to developing and delivering 
appropriate person-centered responses.  
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